| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 33.78B | 32.47B | 37.00B | 40.20B | 38.36B |
| Gross Profit | 9.18B | 9.49B | 9.53B | 9.52B | 8.51B |
| EBITDA | 4.96B | 5.04B | 5.04B | 5.15B | 5.05B |
| Net Income | 3.59B | 3.49B | 3.48B | 3.63B | 3.27B |
Balance Sheet | |||||
| Total Assets | 118.42B | 117.89B | 118.99B | 116.81B | 108.94B |
| Cash, Cash Equivalents and Short-Term Investments | 22.40B | 22.58B | 22.57B | 22.22B | 22.98B |
| Total Debt | 12.42B | 5.48B | 7.32B | 7.14B | 3.59B |
| Total Liabilities | 68.23B | 67.46B | 70.12B | 69.53B | 63.57B |
| Stockholders Equity | 47.36B | 48.03B | 46.81B | 45.32B | 43.55B |
Cash Flow | |||||
| Free Cash Flow | -1.75B | 4.38B | 1.38B | 1.37B | 1.90B |
| Operating Cash Flow | -996.11M | 5.24B | 2.06B | 2.08B | 2.77B |
| Investing Cash Flow | -2.32B | -586.69M | -1.82B | -150.94M | -1.26B |
| Financing Cash Flow | 2.10B | -4.26B | -1.46B | -2.42B | -2.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$203.05B | 13.19 | 9.59% | 4.35% | -0.99% | 80.58% | |
74 Outperform | HK$23.15B | 9.75 | 4.72% | 3.48% | ― | ― | |
66 Neutral | HK$67.46B | 11.56 | 9.85% | 4.07% | 14.48% | 12.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$1.32B | 8.77 | 2.34% | 3.48% | -3.37% | -17.55% | |
59 Neutral | HK$60.07B | 4.48 | 7.81% | 5.51% | 0.19% | 4.36% | |
51 Neutral | HK$2.36B | 47.75 | 7.67% | 0.87% | -14.80% | 11.92% |